Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine
Clinical trial NCT07418229 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07418229
- Sponsor
- Sinovac Biotech Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-09
- Primary completion
- 2026-06-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.